The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer

Carcinoembryonic antigen (CEA) levels and imaging are used to guide treatment for metastatic colorectal cancer (mCRC). This study evaluated changes in CEA and imaging findings in mCRC patients following systemic therapy and their clinical significance, especially the ones with inconsistent results o...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yi-Tien, Chen, Jia-Wan, Chang, Shih-Ching, Jiang, Jeng-Kai, Huang, Sheng-Chieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684139/
https://www.ncbi.nlm.nih.gov/pubmed/36418865
http://dx.doi.org/10.1038/s41598-022-24187-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684139/
https://www.ncbi.nlm.nih.gov/pubmed/36418865
http://dx.doi.org/10.1038/s41598-022-24187-5

Ejemplares similares